Risk of Taking Aspirin Shown In New Study
Taking aspirin, ibuprofen or similar pain
relievers for at least 10 years significantly reduces the risk
of colorectal cancer but also greatly increases the risk of serious
bleeding in the stomach or intestines, a new study shows.
The pain relievers offer no significant protection
to patients who take them for less than a decade, says Andrew
Chan, a gastroenterologist at Massachusetts General Hospital and
lead author of the article, published in Wednesday's Journal
of the American Medical Association.
The more pain relievers people take, the
lower their risk of colo-rectal cancer, the study shows.
Based on the study's results, Chan says,
taking more than 14 aspirin a week might prevent one or two cases
of colorectal cancer in a community of 10,000 people over a year.
However, that amount might also cause eight cases of bleeding
severe enough to require hospitalization or a blood transfusion.
That suggests most people should not take
pain relievers to try to prevent colon cancer, Chan says.
He and his colleagues analyzed 20 years of
data from 83,000 women in the Nurses' Health Study. Chan says
earlier studies suggest that his results probably apply to men
as well, although researchers should confirm them.
Women who took two regular, 325-milligram
aspirin lowered their risk of colon cancer but only after taking
the tablets for more than a decade, Chan says. For example, women
who took more than 14 aspirin a week for at least 10 years had
a 53% lower risk of colorectal cancer. Women who took ibuprofen
or other non-steroidal anti-inflammatory drugs enjoyed similar
benefits.
Chan says his findings confirm the results
of the Women's Health Study, published in the same journal last
month. In that 10-year study of nearly 40,000 women, scientists
also found that taking low doses of aspirin, or 100 milligrams
every other day, did not lower the risk of colon cancer.
Other doctors say the new study's design
could lead researchers to underestimate aspirin's effects. Ernest
Hawk, a prevention expert at the National Cancer Institute, notes
that previous studies have found that smaller doses of aspirin
reduced the risk of colon polyps in only one to three years. About
85% of colon cancers develop from polyps. Those earlier studies,
in which doctors randomly assigned patients to take either aspirins
or placebos, allow doctors to spot smaller changes in less time.
Hawk notes that patients must weigh aspirin's risks against its
benefits for the heart. Studies show that patients at risk for
heart disease can protect themselves by taking much lower daily
doses, such as an 80-milligram pill.
Institute researchers are studying ways to
make aspirin safer, such as by combining it with drugs that protect
the stomach or with other drugs that seem to combat cancer growth,
Hawk says. Doctors are studying calcium and folic acid to prevent
colon cancer.
Eric Jacobs, a senior epidemiologist at the
American Cancer Society, suggests two proven ways to reduce the
risk of cancer: exercise and regular colon screenings beginning
at age 50.
More
articles related to Aspirin
Reference
Source 129
August
26, 2005
For
more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|